| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | SELL | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 19.67▲ | 19.53▲ | 19.58▲ | 21.01▼ | 20.48▼ |
| MA10 | 19.57▲ | 19.50▲ | 19.50▲ | 20.49▼ | 19.79▼ |
| MA20 | 19.56▲ | 19.65▲ | 20.41▼ | 20.37▼ | 17.40▲ |
| MA50 | 19.90▼ | 21.14▼ | 21.07▼ | 18.69▲ | 17.85▲ |
| MA100 | 21.07▼ | 20.74▼ | 20.53▼ | 17.28▲ | N/A |
| MA200 | 21.50▼ | 20.51▼ | 20.46▼ | 17.61▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.071▲ | 0.088▲ | -0.053▼ | -0.154▼ | N/A |
| RSI | 50.271▲ | 43.317▼ | 41.405▼ | 48.178▼ | N/A |
| STOCH | 71.377 | 77.366 | 57.146 | 71.533 | 71.677 |
| WILL %R | -10.680▲ | -10.680▲ | -53.535 | -55.743 | -32.008 |
| CCI | 93.420 | 75.122 | -2.303 | -72.827 | 30.006 |
|
Tuesday, January 14, 2020 07:34 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO (NASDAQ: AVRO) (the “Company”), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today ...
|
|
Tuesday, January 14, 2020 04:47 AM
The FDA has signed off on AVROBIO's (NASDAQ:AVRO) IND for a Phase 1/2 clinical trial evaluating gene therapy AVR-RD-02 for the treatment of Gaucher disease, an inherited disorder caused by the ...
|
|
Monday, December 16, 2019 05:31 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO (NASDAQ: AVRO) (the “Company”), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/01/20 | 19.05 | 19.80 | 18.49 | 19.69 | 95,300 |
| 24/01/20 | 20.76 | 20.92 | 19.28 | 19.60 | 116,100 |
| 23/01/20 | 22.58 | 22.70 | 20.53 | 20.69 | 145,600 |
| 22/01/20 | 22.30 | 22.99 | 21.68 | 22.76 | 283,100 |
| 21/01/20 | 22.80 | 22.80 | 21.34 | 22.29 | 212,300 |
| 17/01/20 | 20.95 | 22.98 | 20.95 | 22.78 | 235,200 |
| 16/01/20 | 20.06 | 20.85 | 19.86 | 20.79 | 128,800 |
| 15/01/20 | 18.56 | 19.95 | 18.46 | 19.83 | 100,400 |
| 14/01/20 | 17.75 | 18.85 | 17.07 | 18.45 | 169,500 |
| 13/01/20 | 19.90 | 19.90 | 17.81 | 17.97 | 142,000 |
|
|
||||
|
|
||||
|
|